BACKGROUND: Valvular and vascular calcification are important early aging phenotypes and represent risk factors for cardiovascular morbidity and mortality. Klotho is a gene primarily expressed in the kidney that has an important role in calcium-phosphate homeostasis. The functional KL-VS variant of Klotho has been associated with aging and cardiovascular disease in human studies, but its role in valvular and vascular calcification remains unknown. We performed a candidate gene study in the Framingham Offspring Cohort to evaluate the effect of KL-VS variant of the Klotho gene on valvular calcification. METHODS: We analyzed the Klotho KL-VS genotype (rs9536314) from the Affymetrix 550K genome-wide dataset, distributed by dbGAP, on 1389 cases and 2139 controls from the Framingham Heart Study Offspring Cohort. Allele and genotype frequencies were compared between cases and controls. Valvular calcification was defined as presence of calcification on the mitral annulus or the aortic valve as determined by echocardiography. A sensitivity analysis of coronary artery calcification by electron beam computed tomography was performed on 1363 patients. RESULTS: The frequency of the TT versus the TG allele was not different between the cases and the controls (39 versus 41%). The KL-VS variant of Klotho was not associated with valvular or vascular calcification, despite adequate power to detect association (86% for odds ratios ≥1.2). In sensitivity analyses, no association (P > 0.001) between other common variants of Klotho, β-Klotho or fibroblast growth factor-23 and the end points of valvular or vascular calcification was observed. CONCLUSIONS: In our adequately powered candidate gene study, we did not observe an association with the functional KL-VS variant of Klotho and presence of valvular or vascular calcification. Future studies aimed at combining cohorts with echocardiographic phenotypes need to be conducted to identify genetic variants associated with valvular calcification.
BACKGROUND: Valvular and vascular calcification are important early aging phenotypes and represent risk factors for cardiovascular morbidity and mortality. Klotho is a gene primarily expressed in the kidney that has an important role in calcium-phosphate homeostasis. The functional KL-VS variant of Klotho has been associated with aging and cardiovascular disease in human studies, but its role in valvular and vascular calcification remains unknown. We performed a candidate gene study in the Framingham Offspring Cohort to evaluate the effect of KL-VS variant of the Klotho gene on valvular calcification. METHODS: We analyzed the Klotho KL-VS genotype (rs9536314) from the Affymetrix 550K genome-wide dataset, distributed by dbGAP, on 1389 cases and 2139 controls from the Framingham Heart Study Offspring Cohort. Allele and genotype frequencies were compared between cases and controls. Valvular calcification was defined as presence of calcification on the mitral annulus or the aortic valve as determined by echocardiography. A sensitivity analysis of coronary artery calcification by electron beam computed tomography was performed on 1363 patients. RESULTS: The frequency of the TT versus the TG allele was not different between the cases and the controls (39 versus 41%). The KL-VS variant of Klotho was not associated with valvular or vascular calcification, despite adequate power to detect association (86% for odds ratios ≥1.2). In sensitivity analyses, no association (P > 0.001) between other common variants of Klotho, β-Klotho or fibroblast growth factor-23 and the end points of valvular or vascular calcification was observed. CONCLUSIONS: In our adequately powered candidate gene study, we did not observe an association with the functional KL-VS variant of Klotho and presence of valvular or vascular calcification. Future studies aimed at combining cohorts with echocardiographic phenotypes need to be conducted to identify genetic variants associated with valvular calcification.
Authors: M Kuro-o; Y Matsumura; H Aizawa; H Kawaguchi; T Suga; T Utsugi; Y Ohyama; M Kurabayashi; T Kaname; E Kume; H Iwasaki; A Iida; T Shiraki-Iida; S Nishikawa; R Nagai; Y I Nabeshima Journal: Nature Date: 1997-11-06 Impact factor: 49.962
Authors: E J Benjamin; J F Plehn; R B D'Agostino; A J Belanger; K Comai; D L Fuller; P A Wolf; D Levy Journal: N Engl J Med Date: 1992-08-06 Impact factor: 91.245
Authors: S Mazzaferro; G Coen; S Bandini; P P Borgatti; M Ciaccheri; D Diacinti; E Ferranti; T Lusenti; G Mancini; I Monducci Journal: Nephrol Dial Transplant Date: 1993 Impact factor: 5.992
Authors: Anton G Kutikhin; Arseniy E Yuzhalin; Elena B Brusina; Anastasia V Ponasenko; Alexey S Golovkin; Olga L Barbarash Journal: Mol Biol Rep Date: 2014-06-06 Impact factor: 2.316
Authors: Anastasia V Ponasenko; Maria V Khutornaya; Anton G Kutikhin; Natalia V Rutkovskaya; Anna V Tsepokina; Natalia V Kondyukova; Arseniy E Yuzhalin; Leonid S Barbarash Journal: Int J Mol Sci Date: 2016-08-31 Impact factor: 5.923
Authors: Rosa Maria R Pereira; Thiago Quadrante Freitas; André Silva Franco; Liliam Takayama; Valeria F Caparbo; Diogo S Domiciano; Luana G Machado; Camille P Figueiredo; Paulo R Menezes; Luiz Fernando Onuchic; Isac de Castro Journal: Sci Rep Date: 2020-05-22 Impact factor: 4.379
Authors: Javier Donate-Correa; Ernesto Martín-Núñez; Rafael Martínez-Sanz; Mercedes Muros-de-Fuentes; Carmen Mora-Fernández; Nayra Pérez-Delgado; Juan F Navarro-González Journal: J Cell Mol Med Date: 2015-11-05 Impact factor: 5.310